CBD has strong anti-inflammatory properties, so it can be a reliable way to get rid of dangerous thyroid inflammation.
Table of Contents
Hashimoto – an autoimmune disease in which the body attacks thyroid cells, causing chronic thyroiditis as a result of stopping the production of its hormones. It is a very difficult disease to detect, most often occurring in mature women, however, often found in men, and even in young children. It is an autoimmune disease that arises as a result of the immune system’s mistake, in the consequence of which the body turns itself against itself, destroying thyroid proteins, recognizing them as hostile. The most common symptoms of Hashimoto:
Researchers have repeatedly demonstrated that the endocannabinoid system is also involved in the regulation of endocrine processes that directly affect the activity of the endocrine glands mentioned above (including thyroid gland). Therefore, appropriate stimulation of the endocannabinoid system using CBD has a direct effect on the hormonal level of the human body.
CBD in the treatment of thyroid gland. Hyperthyroidism
Due to its immunomodulatory properties and ingredients, CBD can bring positive reactions of the body not only in terms of alleviating the symptoms of thyroiditis, but also by acting directly on the destructive inflammatory process. Effective action of cannabidiol is confirmed in such autoimmune diseases as for example: multiple sclerosis or Crohn’s disease. To date, these assumptions have not been scientifically confirmed, but the whole allows us to look at the possible inhibition of thyroid cell destruction due to the positive properties and action of cannabidiol. Patients struggling with hypothyroidism also notice alleviation or even complete elimination of nagging headaches, muscles and joints. CBD allows restoring patients to a restful sleep, increase concentration, eliminating arduous tension and depression.
De Quervain’s disease – (subacute inflammation of the thyroid gland), although the etiology of the disease is not completely clear and known, its causes are sought in a viral infection. The most common symptoms of the de Quervain syndrome are:
Graves’ disease – a type of hyperthyroidism caused by excessive activity of the entire thyroid gland. The cause of Graves’ disease is abnormal functioning of the body’s immune system, which is responsible for fighting all diseases. The main symptoms of the disease include:
CBD in the treatment of thyroid gland. Thyroid hormone – basic knowledge
Hyperthyroidism – otherwise overproduction of thyroid hormones.
In the case of many patients struggling with overactive thyroid using cannabidiol, the relief of many negative symptoms of this disease has been noticed. Regular use of CBD oils allows you to return to normal body weight by stopping the existing diarrhea and restoring the patient’s appetite. CBD also eliminates persistent sleep disorders related to anxiety, irritability and anxiety that accompany Graves’ disease. In addition, the CBD regulates the heart, the trembling of hands and fingers, as well as any muscular pains occurring with varying frequency and intensity in the patient.
1) review benefits and risks of cannabis use, with emphasis on otolaryngic disease processes; 2) define and review the endocannabinoid signaling system (ESS); and 3) review state and federal regulations for the use and research of cannabis and ESS modulators.
Cannabis (marijuana) use is increasing and is currently the most widely used illicit substance both worldwide and within the United States. 1 Cannabis has been used for centuries as a treatment for myriad medical ailments. It has shown potential to be of therapeutic use in several pathologies including nausea, pain, weight/appetite loss, inflammation, anxiety, multiple sclerosis‐related muscle spasticity, neuropathy, seizure, and even cancer. 2 , 3 , 4 , 5 , 6 , 7 , 8 There has been a recent resurgence of interest in its therapeutic potential, which is likely due to a combination of changing societal perceptions, new scientific discoveries, and recent legislation measures relating to its regulation. The legal classification of cannabis is complicated due to conflicting legislation of the state and federal governments. At present, the federal government still classifies marijuana as a schedule I controlled substance and does not approve it for any medical uses. At the state level, 29 states and the District of Columbia have legalized comprehensive medical marijuana and cannabis programs, while an additional 17 states have highly regulated medical marijuana programs legalizing its use in more limited medical situations. This means that for patients in a majority of states, medical marijuana is increasingly becoming an accessible and entirely novel option for management of their ailments. The current increase in use for medical purposes appears to be commensurate with recent changes in state and federal legislative policies as well as international studies demonstrating a biochemical basis for the therapeutic effects seen with cannabis use. As the use of marijuana and other complementary medicine therapies continues to rise, patients may expect their physicians to explain both the potential merits and harms they may experience with its use.
Although there are many biologically active phytocannabinoids in cannabis, two predominate in the current literature. In 1964, Gaoni and Mechoulam described the psychoactive cannabinoids found in Cannabis sativa: Δ8‐tetrahydrocannabinol (Δ8‐THC) and Δ9‐tetrahydrocannabinol (Δ9‐THC). 9 Δ9‐THC is more potent and found in higher concentrations within the plant. It is the primary cannabinoid referred to when “THC” is referenced in this paper. THC is metabolized within the lungs and liver into 11‐hydroxy‐Δ9‐THC which is active within the CNS and elsewhere. 10 Jean‐Baptiste Lamarck described Cannabis indica as a second strain of cannabis in 1785. Cannabis indica is clinically distinct from Cannabis sativa due to the higher relative concentration of cannabidiol (CBD), another phytocannabinoid.